Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
08/2012
08/15/2012CN102639136A Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
08/15/2012CN102633863A New approach to treat intraocular hypertension
08/15/2012CN102633716A Bicyclic inhibitors of mek and methods of use thereof
08/15/2012CN102631668A Application of biomedical fibrin glue serving as medicament for treating lacrimal duct obstruction diseases
08/15/2012CN102631623A Traditional Chinese medicine composite for treating thyroid associated ophthalmopathy and preparation method thereof
08/15/2012CN102631586A Medicinal moxibustion preparation for treating myopia and amblyopia
08/15/2012CN102631558A Medicament for treating eye disease and preparation method of medicament
08/15/2012CN102631557A Traditional Chinese medicine composition for treating cataract, external oculopathy, presbyopia and myopia and preparation method thereof
08/15/2012CN102631548A Medicament for treating burns and otitis media and preparation method thereof
08/15/2012CN102631539A Chinese patent medicine for treating trachoma and preparation method thereof
08/15/2012CN102631533A Traditional Chinese medicine (TCM) for treating diabetic retinopathy
08/15/2012CN102631485A Traditional Chinese medicine for treating keratitis
08/15/2012CN102631477A Traditional Chinese medicine for treating keratitis
08/15/2012CN102631339A Oral salvianolic acid A medicine composition containing borneol and application thereof
08/15/2012CN102631320A Betahistine hydrochloride liposome and preparation method thereof
08/15/2012CN102631318A Preparation method of indometacin liposome eye drops
08/15/2012CN101947307B Applications of human placenta peptide in preparing drugs for treating dry eye syndrome and other ocular surface diseases
08/15/2012CN101658493B Azithromycin nanostructured lipid carrier and preparation method thereof
08/15/2012CN101495463B Seven-membered ring compound, production method thereof and pharmaceutical use thereof
08/15/2012CN101495117B Aqueous liquid preparation containing amide compound
08/15/2012CN101304979B Quinazoline derivative and pharmaceutical
08/15/2012CN101203251B 玻璃体可视化剂 Vitreous visualization agent
08/14/2012US8242256 siRNA useful to supress expression of EIF-5A1
08/14/2012US8242147 Aryl ureas with angiogenisis inhibiting activity
08/14/2012US8242118 Arylsulfonamide derivatives for use as CCR3 antagonists in the treatment of inflammatory and immunological disorders
08/14/2012US8242099 Implants and methods for treating inflammation-mediated conditions of the eye
08/14/2012US8242090 Vascular therapeutics
08/14/2012US8239978 Vision through photodynamic therapy of the eye
08/14/2012CA2514971C Regeneration and neogenesis of retinal photoreceptor cell using otx2 gene
08/14/2012CA2498233C Clear ophthalmic solution comprising latanoprost as active ingredient
08/09/2012WO2012106725A2 Methods and compositions for treating occular disorders
08/09/2012WO2012106118A2 Method of making ophthalmic devices and components thereof from hydrophobic acrylic (ha) polymers with reduced or eliminated glistenings
08/09/2012WO2012105854A2 Compositions for administration to the eye
08/09/2012WO2012105674A1 Drug therapy for preventing or treating glaucoma
08/09/2012WO2012105610A1 Medicinal agent for prevention or treatment of diseases associated with intraocular neovascularization and/or intraocular vascular hyperpermeability
08/09/2012WO2012105573A1 CYCLIC SULFONIUM SALT, PROCESS FOR PRODUCTION OF SAME, AND α-GLUCOSIDASE INHIBITOR COMPRISING SAME
08/09/2012WO2012104788A2 Anti-angiogenic compounds, pharmaceutical compositions containing same, and use thereof
08/09/2012WO2012103813A1 Danshensu and chuanxiongqin derivatives, process for preparation, and use thereof
08/09/2012WO2012047587A3 Mdm2 inhibitors for treatment of ocular conditions
08/09/2012WO2011163452A8 Treating surface of the eye disorders
08/09/2012WO2011133964A3 Methods and compositions for preserving photoreceptor and retinal pigment epithelial cells
08/09/2012US20120204282 Methods and compositions for treating occular disorders
08/09/2012US20120203162 Method for treating neovascularization
08/09/2012US20120203161 Deuterated water and riboflavin solution for extending singlet oxygen lifetimes in treatment of ocular tissue and method of use
08/09/2012US20120202885 Methods, assays and compositions for treating retinol-related diseases
08/09/2012US20120202865 Substituted-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors
08/09/2012US20120202864 Compositions and Methods for Treatment of Glaucoma
08/09/2012US20120202863 Compositions and methods for treatment of glaucoma
08/09/2012US20120202862 Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
08/09/2012US20120202861 Novel estrogen receptor ligands
08/09/2012US20120202847 Novel Tetrahydroisoquinoline Compounds
08/09/2012US20120202837 Spirocyclic piperidine derivatives useful as renin inhibitors
08/09/2012US20120202821 Conformationally constrained, fully synthetic macrocyclic compounds
08/09/2012US20120202818 Ureidophenyl substituted triazine derivatives and their therapeutical applications
08/09/2012US20120202817 Compounds having 4-pyridylalkylthio group as a substituent
08/09/2012US20120202810 Substituted 4-aminocyclohexane derivatives
08/09/2012US20120202809 Novel n-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazole derivatives as pkc kinase inhibitors
08/09/2012US20120202808 Novel thiophenediamine derivative having urea structure
08/09/2012US20120202790 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists
08/09/2012US20120202769 Fgf receptor-activating n-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof
08/09/2012US20120202763 Methods for treating cancer and non-neoplastic conditions
08/09/2012US20120202758 Core 2glcnac-t inhibitors
08/09/2012US20120201910 Artificial Tears and Therapeutic Uses
08/09/2012US20120201884 Extracts, fractions and compositions comprising acetogenins and their applications
08/09/2012US20120201859 Drug Delivery Systems and Use Thereof
08/09/2012US20120201831 Human antibodies that bind human il-12 and methods for producing
08/09/2012US20120201830 Compositions and methods for treating macular edema
08/09/2012US20120201800 Methods and Devices for Sustained In-Vivo Release Of an Active Agent
08/09/2012US20120201791 Methods of treating diseases or conditions using mesenchymal stem cells
08/09/2012US20120201787 Treatment of spinal cord injury and traumatic brain injury using amnion derived adherent cells
08/08/2012EP2484675A1 Novel phenylpyridine derivative and medicinal agent comprising same
08/08/2012EP2484384A1 Eye drops
08/08/2012EP2484354A1 Antioxidant composition
08/08/2012EP2484353A1 Oral composition for alleviation of ultraviolet radiation-induced damage
08/08/2012EP2483332A1 Crosslinked hydrogels and related method of preparation
08/08/2012EP2482814A1 Methods and compositions for treatment of ocular fibrosis
08/08/2012EP2482804A1 Microparticle compositions and methods for treating age-related macular degeneration
08/08/2012EP2482788A2 Topical tetracycline compositions
08/08/2012EP2205253B1 Composition and method inhibiting inflammation
08/08/2012EP2190447B1 His-Pro-Gly-Ser-Arg-lle-Val-Leu-Ser-Leu-Asp-Val-Pro-lle-Gly-Leu-Leu-Gln-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Ala-Arg-Ala-Ala-Arg-Glu-Gln-Ala-Thr-Thr-Asn-Ala-Arg-ile-Leu-Ala-Arg-Val-NH2 for use in anti-angiogenic therapy
08/08/2012EP2187901B1 Neuropeptide El optionally combined with ACTH (7-38) for use in anti-angiogenic therapy
08/08/2012EP2041128B1 Substituted gamma lactams as therapeutic agents
08/08/2012EP2035004B1 Phenyl substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity
08/08/2012EP1819670B1 12-aryl prostaglandin analogs
08/08/2012EP1614419B1 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof
08/08/2012EP1169038B1 Cyclic protein tyrosine kinase inhibitors
08/08/2012EP0837938B1 Use of mp52 or mp121 for treating and preventing diseases of the nervous system
08/08/2012CN102627676A C-aryl glucoside sglt2 inhibitors and method
08/08/2012CN102627640A Heterobicyclic compounds useful as p38 kinase inhibiting agents
08/08/2012CN102626436A Preparation method of liuwei eyesight improving pharmaceutical composition
08/08/2012CN102626429A Method for water-bath extraction of castanea mollissina Blume involucre polyphenols
08/08/2012CN102626428A Ginkgo leaf extract osmotic pump controlled-release preparation and preparation method thereof
08/08/2012CN102626390A Gastrodin multiphase liposome injection
08/08/2012CN102626224A Eyesight improving agent composited by wild berries and Chinese medicines and preparation method thereof
08/08/2012CN101935363B Method for producing pharmaceutical grade hyaluronic acid
08/08/2012CN101310771B 视觉功能障碍改善剂 Visual dysfunction improving agent
08/07/2012US8236951 Thioxanthine derivatives as myeloperoxidase inhibitors
08/07/2012US8236798 Carboxamide compounds and their use as calpain inhibitors
08/07/2012CA2513544C An otorhinological delivery device
08/07/2012CA2477737C Multi-substituted selective androgen receptor modulators and methods of use thereof
1 ... 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 ... 531